Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2000-1-13
pubmed:abstractText
Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are important in tumor development and progression. MMP expression has been correlated with advanced clinical stage and poor survival in some tumors, but data for small-cell lung cancer (SCLC) are lacking. The aim of this study was to assess the expression of MMPs and TIMPs in SCLC and to evaluate their importance relative to standard prognostic factors.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1802-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10561218-Carcinoma, Small Cell, pubmed-meshheading:10561218-Female, pubmed-meshheading:10561218-Humans, pubmed-meshheading:10561218-Immunohistochemistry, pubmed-meshheading:10561218-In Situ Hybridization, pubmed-meshheading:10561218-Lung Neoplasms, pubmed-meshheading:10561218-Male, pubmed-meshheading:10561218-Metalloendopeptidases, pubmed-meshheading:10561218-Middle Aged, pubmed-meshheading:10561218-Multivariate Analysis, pubmed-meshheading:10561218-Neoplasm Staging, pubmed-meshheading:10561218-Predictive Value of Tests, pubmed-meshheading:10561218-Prognosis, pubmed-meshheading:10561218-RNA, Messenger, pubmed-meshheading:10561218-Sex Factors, pubmed-meshheading:10561218-Survival Rate, pubmed-meshheading:10561218-Tissue Inhibitor of Metalloproteinase-1, pubmed-meshheading:10561218-Tissue Inhibitor of Metalloproteinase-2, pubmed-meshheading:10561218-Tissue Inhibitor of Metalloproteinase-3, pubmed-meshheading:10561218-Tissue Inhibitor of Metalloproteinases
pubmed:year
1999
pubmed:articleTitle
Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer.
pubmed:affiliation
Department of Medical Biophysics, Laboratory Medicine and Pathobiology, and Biostatistics, Princess Margaret Hospital/Ontario Cancer Institute, The Toronto Hospital, and the University of Toronto, Ontario, Canada.
pubmed:publicationType
Journal Article